Exchange Traded Concepts LLC trimmed its position in shares of SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) by 31.8% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 35,372 shares of the company’s stock after selling 16,487 shares during the period. Exchange Traded Concepts LLC’s holdings in SIGA Technologies were worth $239,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in the company. Allspring Global Investments Holdings LLC boosted its position in SIGA Technologies by 11.6% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 52,526 shares of the company’s stock worth $450,000 after purchasing an additional 5,468 shares during the period. BNP Paribas Financial Markets boosted its position in SIGA Technologies by 297.7% during the 1st quarter. BNP Paribas Financial Markets now owns 59,053 shares of the company’s stock worth $505,000 after purchasing an additional 44,205 shares during the period. Vanguard Group Inc. boosted its position in SIGA Technologies by 1.9% during the 1st quarter. Vanguard Group Inc. now owns 2,283,612 shares of the company’s stock worth $19,548,000 after purchasing an additional 41,515 shares during the period. Hillsdale Investment Management Inc. purchased a new stake in SIGA Technologies during the 1st quarter worth $1,367,000. Finally, CANADA LIFE ASSURANCE Co boosted its position in SIGA Technologies by 996.5% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 24,836 shares of the company’s stock valued at $212,000 after buying an additional 22,571 shares during the last quarter. 55.40% of the stock is currently owned by institutional investors and hedge funds.
SIGA Technologies Price Performance
NASDAQ:SIGA opened at $6.92 on Monday. The firm has a 50-day moving average of $8.08 and a two-hundred day moving average of $8.24. The stock has a market cap of $492.17 million, a P/E ratio of 6.29 and a beta of 0.90. SIGA Technologies, Inc. has a 1-year low of $4.26 and a 1-year high of $12.83.
SIGA Technologies Company Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Featured Articles
- Five stocks we like better than SIGA Technologies
- Using the MarketBeat Dividend Tax Calculator
- Is Spotify Stock Poised to Soar? Options Traders Think So
- Canadian Penny Stocks: Can They Make You Rich?
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Want to see what other hedge funds are holding SIGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report).
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.